Wednesday, February 11, 2026

Apple: Analysts Anticipate Q4 Revenues Of $84.85 Billion

Apple (NASDAQ: AAPL) will be reporting its fourth quarter financial results on October 27th after markets close. Analysts have a consensus $168.89 12-month price target on the company, via a total of 41 analysts, with 14 analysts having strong buy ratings. 20 analysts meanwhile have buy ratings and 7 have hold ratings on the company. The street high comes from Atlantic Equities with a $190 price target, and the lowest target sits at $132.

24 analysts have revenue estimates for the fourth quarter. The mean revenue estimate between all 24 analysts is $84.85 billion; this number has been revised upwards from $77.87 at the start of April. The highest revenue estimate is $89.28 billion, while the lowest is $77.65 billion.

Onto EBITDA estimates, there are currently 9 analysts who have fourth-quarter EBITDA estimates. The mean is currently $26.82 billion, with this number having been revised upwards from $22.21 billion at the start of April. The street high estimate currently sits at $29.20 billion in EBITDA and the lowest is $22.85 billion.

Analysts estimate that quarterly earnings per share will come in at $1.24, with this number being revised upwards from $0.98 at the start of April. Street high is $1.34 and the lowest estimate is $1.05 per share for the quarter.


Information for this briefing was found via Edgar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Back to the Cariboo: Gold Rush History Meets Modern Discovery | Golden Caribou

Gold Prices Are High, Experience Matters | Rob McLeod

Silver Is a Wild Animal, Gold Heads for $6,000 in 2026 | Craig Hemke

Recommended

Canadian Copper Plans 2,500 Metre Drill Program For 2026

Mercado Receives Permits For Planned 3,000 Metre Drill Program At Copalito

Related News

CareRx: Canaccord Raises Price Target To $6.50 Following Financing

Earlier this week, CareRx Corp (TSX: CRRX) closed their C$21.2 million bought deal. Notably, $6.25...

Friday, February 5, 2021, 11:45:00 AM

Valens Sees Eight Capital, Haywood, Canaccord Slash Price Targets Following Q2 Financials

Last Wednesday, The Valens Company (TSX: VLNS) released its financial statements for the second quarter...

Monday, July 20, 2020, 11:04:54 AM

WeCommerce: TD, Canaccord Raise Price Targets After Leading Bought Deal

Last week, WeCommerce (TSXV: WE) announced that their bought deal closed. The company issued 2.81...

Friday, July 16, 2021, 04:09:00 PM

Hive Blockchain: Canaccord Remains Positive On Outlook

On August 26th, Canaccord Genuity Capital Markets’ raised their 12-month price target on Hive Blockchain...

Monday, August 29, 2022, 02:22:00 PM

Aurora: Canaccord Raises Price Target To $14.00 On Back Of Earnings

Last night, Aurora Cannabis (TSX: ACB) (NYSE: ACB) reported its second quarter 2020 earnings. They...

Friday, February 12, 2021, 04:02:00 PM